This trial is testing a new drug to see if it can reduce the risk of infection and graft vs. host disease in adults undergoing stem cell transplantation.
4 Primary · 8 Secondary · Reporting Duration: Day 365
2 Treatment Groups
Cohort 1 - Open Label Study
1 of 2
Cohort 2 - Randomized, Double-Blind, Placebo-Controlled Study
1 of 2
75 Total Participants · 2 Treatment Groups
Primary Treatment: SER-155 · Has Placebo Group · Phase 1
Who is running the clinical trial?
Age 18+ · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Could you elaborate on the research that has been done concerning SER-155?
"Presently, there are 55 SER-155 trials in progress. Of these studies, 6 have reached the third phase of clinical trial testing. Although a majority of these evaluations take place near Jupiter, Florida, there are 315 other locations running trials for this medication." - Anonymous Online Contributor
How many research sites are conducting this experiment?
"In addition to Mayo Clinic - Scottsdale in Scottsdale, Arizona, University of Florida - Division of Hematology & Oncology in Gainesville, Washington and Fred Hutchinson Cancer Research Center in Seattle Massachusetts; 8 other clinical sites are participating this trial." - Anonymous Online Contributor
What is the current size of the patient cohort for this investigation?
"To satisfactorily complete this clinical trial, a total of 75 participants must be recruited that meet the selection criteria. Patients can join the study at Mayo Clinic - Scottsdale in Scottsdale, Arizona and University of Florida - Division of Hematology & Oncology in Gainesville, Washington." - Anonymous Online Contributor
Are there any available opportunities for participants in this experiment?
"Confirmed. According to clinicaltrials.gov, this medical trial has been open for recruitment since November 24th 2021 and was last updated on the 7th of November 2022 - it is still actively seeking participants." - Anonymous Online Contributor
What medical conditions has SER-155 proven to be most effective in treating?
"SER-155 is a clinically approved treatment for staphylococcal infections, the various illnesses caused by staphylococci, and enterocolitis resulting from Staphylococcus aureus." - Anonymous Online Contributor
Are there any documented hazards to taking SER-155?
"Due to the initial stage of clinical research, SER-155's safety rating is estimated to be 1 on a scale from 1 to 3. This is because there are limited studies confirming its efficacy and safety." - Anonymous Online Contributor